These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 8397948)
21. Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty. Rhodes T; Davis M; Judd A Addiction; 2004 May; 99(5):621-33. PubMed ID: 15078237 [TBL] [Abstract][Full Text] [Related]
22. An analysis of respondent-driven sampling with injecting drug users in a high HIV prevalent state of India. Phukan SK; Medhi GK; Mahanta J; Adhikary R; Thongamba G; Paranjape RS; Akoijam BS Harm Reduct J; 2017 Jul; 14(1):41. PubMed ID: 28673303 [TBL] [Abstract][Full Text] [Related]
23. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data. Bird SM; Goldberg DJ; Hutchinson SJ J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088 [TBL] [Abstract][Full Text] [Related]
24. Changes in the injecting risk behaviour of injecting drug users in London, 1990-1993. Hunter GM; Donoghoe MC; Stimson GV; Rhodes T; Chalmers CP AIDS; 1995 May; 9(5):493-501. PubMed ID: 7639975 [TBL] [Abstract][Full Text] [Related]
25. Edinburgh drug users: are they injecting and sharing less? Peters AD; Reid MM; Griffin SG AIDS; 1994 Apr; 8(4):521-8. PubMed ID: 8011257 [TBL] [Abstract][Full Text] [Related]
26. Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment of Rio de Janeiro. Lima ES; Friedman SR; Bastos FI; Telles PR; Friedmann P; Ward TP; des Jarlais DC Addiction; 1994 Jun; 89(6):689-98. PubMed ID: 8069170 [TBL] [Abstract][Full Text] [Related]
27. Was the 1988 HIV epidemic among Bangkok's injecting drug users a common source outbreak? Wright NH; Vanichseni S; Akarasewi P; Wasi C; Choopanya K AIDS; 1994 Apr; 8(4):529-32. PubMed ID: 8011258 [TBL] [Abstract][Full Text] [Related]
28. HIV infection and AIDS among drug injectors at Rio de Janeiro: perspectives and unanswered questions. Lima ES; Bastos FI; Telles PR; Friedman SR Bull Narc; 1993; 45(1):107-15. PubMed ID: 8305901 [TBL] [Abstract][Full Text] [Related]
29. Continued high prevalence of HIV, HBV and HCV among injecting and noninjecting drug users in Italy. Camoni L; Regine V; Salfa MC; Nicoletti G; Canuzzi P; Magliocchetti N; Rezza G; Suligoi B; Ann Ist Super Sanita; 2010; 46(1):59-65. PubMed ID: 20348620 [TBL] [Abstract][Full Text] [Related]
30. Factors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biological survey in Manipur and Nagaland, India. Ganju D; Ramesh S; Saggurti N Harm Reduct J; 2016 Jun; 13(1):21. PubMed ID: 27324253 [TBL] [Abstract][Full Text] [Related]
31. Role of drug injection in the spread of HIV in Argentina and Brazil. Libonatti O; Lima E; Peruga A; González R; Zacarías F; Weissenbacher M Int J STD AIDS; 1993; 4(3):135-41. PubMed ID: 8324042 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of HIV infection in provincial prisons in British Columbia. Rothon DA; Mathias RG; Schechter MT CMAJ; 1994 Sep; 151(6):781-7. PubMed ID: 8087754 [TBL] [Abstract][Full Text] [Related]
33. HIV infection in injecting drug users attending centres in England and Wales, 1990-1991. Noone A; Durante AJ; Brady AR; Majid F; Swan AV; Parry JV; Hart GJ; Connell JA; Perry KR; Joce RE AIDS; 1993 Nov; 7(11):1501-7. PubMed ID: 8280418 [TBL] [Abstract][Full Text] [Related]
34. HIV surveillance by testing saliva from injecting drug users: a national study in New Zealand. Dickson NP; Austin FJ; Paul C; Sharples KJ; Skegg DC J Epidemiol Community Health; 1994 Feb; 48(1):55-7. PubMed ID: 8138771 [TBL] [Abstract][Full Text] [Related]
35. Injecting drug use and HIV infection in southwest China. Zheng X; Tian C; Choi KH; Zhang J; Cheng H; Yang X; Li D; Lin J; Qu S; Sun X AIDS; 1994 Aug; 8(8):1141-7. PubMed ID: 7986413 [TBL] [Abstract][Full Text] [Related]
36. Stimulant injectors in Ukraine: the next wave of the epidemic? Booth RE; Lehman WE; Kwiatkowski CF; Brewster JT; Sinitsyna L; Dvoryak S AIDS Behav; 2008 Jul; 12(4):652-61. PubMed ID: 18264752 [TBL] [Abstract][Full Text] [Related]
37. Reducing HIV infection among new injecting drug users in the China-Vietnam Cross Border Project. Des Jarlais DC; Kling R; Hammett TM; Ngu D; Liu W; Chen Y; Binh KT; Friedmann P AIDS; 2007 Dec; 21 Suppl 8():S109-14. PubMed ID: 18172378 [TBL] [Abstract][Full Text] [Related]
38. Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting drug users. Hartgers C; van Ameijden EJ; van den Hoek JA; Coutinho RA Public Health Rep; 1992; 107(6):675-81. PubMed ID: 1454980 [TBL] [Abstract][Full Text] [Related]
39. Demographic, HIV risk behavior, and health status characteristics of "crack" cocaine injectors compared to other injection drug users in three New England cities. Buchanan D; Tooze JA; Shaw S; Kinzly M; Heimer R; Singer M Drug Alcohol Depend; 2006 Feb; 81(3):221-9. PubMed ID: 16171952 [TBL] [Abstract][Full Text] [Related]
40. HIV infection and patterns of risk among women drug injectors and crack users in low and high sero-prevalence sites. Tortu S; Beardsley M; Deren S; Williams M; McCoy HV; Stark M; Estrada A; Goldstein M AIDS Care; 2000 Feb; 12(1):65-76. PubMed ID: 10716019 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]